Longitudinal evaluation of prostate-specific antigen levels in men with and without prostate disease (Q24632629)

2

0 references

E J Metter

3

0 references

L J Brant

4

0 references

D W Chan

5

0 references

R Andres

6

0 references

J L Fozard

7

0 references

P C Walsh

8

0 references

language of work or name

English

0 references

publication date

April 1992

1 reference

The Journal of the American Medical Association

published in

0 references

volume

267

0 references

issue

16

0 references

page(s)

2215-20

0 references

cites work

Measurement of Prostate-Specific Antigen in Serum as a Screening Test for Prostate Cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3461837

Cumulative prevalence of prostatism matches the autopsy prevalence of benign prostatic hyperplasia

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3461837

Prostate Cancer Detection in a Clinical Urological Practice by Ultrasonography, Digital Rectal Examination and Prostate Specific Antigen

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3461837

Symptoms and signs of prostatism as risk factors for prostatectomy

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3461837

Purification of a human prostate specific antigen

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3461837

Proliferative Activity of Benign Human Prostate, Prostatic Adenocarcinoma and Seminal Vesicle Evaluated by Thymidine Labeling

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3461837

Clinical use of prostate specific antigen in patients with prostate cancer

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3461837

Prostate specific antigen in the preoperative and postoperative evaluation of localized prostatic cancer treated with radical prostatectomy.

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3461837

Prostate specific antigen in the diagnosis and treatment of adenocarcinoma of the prostate. IV. Anti-androgen treated patients

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3461837

Prostate specific antigen in the diagnosis and treatment of adenocarcinoma of the prostate. II. Radical prostatectomy treated patients

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3461837

The development of human benign prostatic hyperplasia with age

28 November 2018

1 reference

https://pubmed.ncbi.nlm.nih.gov/1372942

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Prostate-specific antigen as a serum marker for adenocarcinoma of the prostate

1 reference

https://pubmed.ncbi.nlm.nih.gov/1372942

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

The influence of reversible androgen deprivation on serum prostate-specific antigen levels in men with benign prostatic hyperplasia

1 reference

https://pubmed.ncbi.nlm.nih.gov/1372942

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1001/JAMA.1992.03480160073037

0 references

10.1001/JAMA.267.16.2215

1 reference

1825405

1825405

1 reference

1 reference

1 reference